These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31501263)

  • 1. Hepatitis C Virus Structure: Defined by What It Is Not.
    Dearborn AD; Marcotrigiano J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus E2 envelope glycoprotein core structure.
    Kong L; Giang E; Nieusma T; Kadam RU; Cogburn KE; Hua Y; Dai X; Stanfield RL; Burton DR; Ward AB; Wilson IA; Law M
    Science; 2013 Nov; 342(6162):1090-4. PubMed ID: 24288331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.
    Vasiliauskaite I; Owsianka A; England P; Khan AG; Cole S; Bankwitz D; Foung SKH; Pietschmann T; Marcotrigiano J; Rey FA; Patel AH; Krey T
    mBio; 2017 May; 8(3):. PubMed ID: 28512091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
    Khan AG; Whidby J; Miller MT; Scarborough H; Zatorski AV; Cygan A; Price AA; Yost SA; Bohannon CD; Jacob J; Grakoui A; Marcotrigiano J
    Nature; 2014 May; 509(7500):381-4. PubMed ID: 24553139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into hepatitis C virus receptor binding and entry.
    Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
    Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis C virus envelope protein complex is a dimer of heterodimers.
    Augestad EH; Holmboe Olesen C; Grønberg C; Soerensen A; Velázquez-Moctezuma R; Fanalista M; Bukh J; Wang K; Gourdon P; Prentoe J
    Nature; 2024 Sep; 633(8030):704-709. PubMed ID: 39232163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
    Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
    J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.
    Fenouillet E; Lavillette D; Loureiro S; Krashias G; Maurin G; Cosset FL; Jones IM; Barbouche R
    J Biol Chem; 2008 Sep; 283(39):26340-8. PubMed ID: 18667425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Torrents de la Peña A; Sliepen K; Eshun-Wilson L; Newby ML; Allen JD; Zon I; Koekkoek S; Chumbe A; Crispin M; Schinkel J; Lander GC; Sanders RW; Ward AB
    Science; 2022 Oct; 378(6617):263-269. PubMed ID: 36264808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
    Prentoe J; Bukh J
    Front Immunol; 2018; 9():2146. PubMed ID: 30319614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
    Gopal R; Jackson K; Tzarum N; Kong L; Ettenger A; Guest J; Pfaff JM; Barnes T; Honda A; Giang E; Davidson E; Wilson IA; Doranz BJ; Law M
    PLoS Pathog; 2017 Dec; 13(12):e1006735. PubMed ID: 29253863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder.
    Yost SA; Wang Y; Marcotrigiano J
    Front Immunol; 2018; 9():1917. PubMed ID: 30197646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.
    Urbanowicz RA; McClure CP; Brown RJ; Tsoleridis T; Persson MA; Krey T; Irving WL; Ball JK; Tarr AW
    J Virol; 2015 Dec; 90(7):3288-301. PubMed ID: 26699643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.
    Ströh LJ; Krey T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.